[Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy; D003036:Cobalt Isotopes / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007414:Intestinal Neoplasms / Q000188:drug therapy; D007822:Laryngeal Neoplasms / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D008727:Methotrexate / Q000627:therapeutic use; D008937:Mitomycins / Q000009:adverse effects / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy; D010166:Palliative Care; D010610:Pharyngeal Neoplasms / Q000188:drug therapy; D012509:Sarcoma / Q000188:drug therapy; D013852:Thiotepa / Q000627:therapeutic use; D014062:Tongue Neoplasms / Q000188:drug therapy; D014565:Urogenital Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D003036:Cobalt Isotopes; D004338:Drug Combinations; D008937:Mitomycins; D014747:Vinblastine; D003520:Cyclophosphamide; D013852:Thiotepa; D005472:Fluorouracil; D008727:Methotrexate
La mitomycine seule et en association thérapeutique dans le traitement palliatif des tumeurs solides.